Tehran University of Medical Sciences

Science Communicator Platform

Share By
Covid-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases Publisher Pubmed



Ghiasvand F1 ; Ghadimi M2 ; Sadr S3 ; Jafari F3, 4 ; Manafi N4 ; Ahmadinejad Z1 ; Tirgar S5 ; Seyedalinaghi S6
Authors

Source: Infectious Disorders - Drug Targets Published:2021


Abstract

Background: Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is limited data on its efficacy. Case Presentation: We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful out-come. Conclusion: We have presented evidence of the potential beneficial effect of the azithromycin in the treatment of patients with COVID-19 in three different clinical settings. More evidence is need-ed regarding the microbiological data, safety, and efficacy of this medication in the management of COVID-19. © 2021 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Current Treatments and Therapeutic Options for Covid-19 Patients: A Systematic Review, Infectious Disorders - Drug Targets (2022)
2. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
3. Safety and Efficacy of Imatinib, Nilotinib, and Artesunate in Covid-19 Patients: A Systematic Review of Current Evidence, Anti-Infective Agents (2024)
Experts (# of related papers)
View all Related Experts
Seyed Ahmad Seyed Alinaghi (2)
Mohammad Sharifzadeh (1)
Other Related Docs
4. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
5. Post-Exposure Prophylaxis for Covid-19: A Systematic Review, Infectious Disorders - Drug Targets (2023)
6. Therapeutic Potentials and Candidates for Covid-19, Iranian Journal of Science (2023)
7. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
8. Comparison of the Eight Different Treatment Regimens for the Hospitalized Patients With Covid-19: A Retrospective Cohort Study, Journal of Cellular and Molecular Anesthesia (2021)
9. Therapeutic Status of Famotidine in Covid-19 Patients: A Review, Infectious Disorders - Drug Targets (2022)
10. Antiviral Therapy Inmanagement of Covid-19: A Systematic Review on Current Evidence, Archives of Academic Emergency Medicine (2020)
11. Covid-19: A Review on Treatment Strategies and Candidate Vaccines, Scientific Journal of Kurdistan University of Medical Sciences (2021)
12. Therapeutic Uses of Antihistamines in the Management of Covid-19: A Narrative Review, Anti-Infective Agents (2023)
13. Safety and Efficacy of Hydroxychloroquine and Chloroquine in Treatment of Covid-19: A Rapid Review of Evidence, Health Technology Assessment in Action (2020)
14. Real Clinical Practice and Therapeutic Management Following Covid-19 Crisis in Two Hospitals in Iran: A Statistical and Conceptual View, Tanaffos (2020)
15. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
16. Traditional Persian Medicine As a Holistic Therapeutic Approach for Managing Covid-19, Traditional Medicines and Natural Products as Preventive and Therapeutic Agents against COVID-19: a Promising Response to the Global Unprecedented Pandemic (2024)
17. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
18. Treatment of Covid-19 With Pentoxifylline: Could It Be a Potential Adjuvant Therapy?, Dermatologic Therapy (2020)
19. The Emergence of Novel Coronavirus Disease, Global Treatment Update and Its Containment Strategies in Overpopulated Countries: A Review, Coronaviruses (2021)
20. Comparing the Effectiveness and Safety of Remdesivir and Molnupiravir in Covid-19: A Systematic Review and Meta-Analysis, Immunity, Inflammation and Disease (2025)